Choose Your News
Loading...
Thumbnail
The company lost more than $1M in first quarter of 2018 amid waning sales of $750 pill. [Read More]
Thumbnail
MoneyTaker strikes again. [Read More]
MoneyTaker strikes again. [Read More]
Thumbnail
Yet another accurate model prediction—seasonal patterns around the world. [Read More]
Thumbnail
New key membranes aren't just for keeping typing noise to a minimum. [Read More]
Thumbnail
Loon's first deal: Telkom Kenya will provide the Internet signals; balloons will amplify. [Read More]
Thumbnail
FCC sends Sinclair/Tribune merger into purgatory—vote refers deal to a judge. [Read More]
Thumbnail
We don't know much about the next Halo game, but we know one thing it's not. [Read More]
Thumbnail
Our final episode for the week looks at the good—and bad—of knowing our genes. [Read More]
It should reach the market in "the next several months." [Read More]
Telling the time is going to be a whole lot more accurate. [Read More]
A mysterious ancient text has finally been deciphered, and it's a medical essay. [Read More]
Fox preferred to sell to Disney, and Comcast (eventually) took the hint. [Read More]
Given a set of starting materials, it'll figure out every reaction among them. [Read More]
FDA head says current products don't meet labeling standards, guidance coming soon. [Read More]
"Within this, those principles have real trade-offs and real tug on each other." [Read More]
Including deals on Samsung SSDs, the Apple Watch, Dell laptops, and more. [Read More]
IAI's Rotem UAS can act as an eye in the sky—and as death from above. [Read More]
Solar can help avoid costs for utilities, which is both good and bad for them. [Read More]
"If you want to get good at spaceflight, you have to practice." [Read More]
Loading...
Preview